Cancer BiologybioRxivPreprint
TRIB2 supports a high glycolytic phenotype in melanoma cells
Víctor Mayoral-Varo, Ana Luísa De Sousa‐Coelho, Carla Lopes…·Wolfgang Link
This study shows TRIB2 promotes glycolysis in melanoma cells, contributing to therapy resistance and suggesting it as a potential therapeutic target.
DOI 10.1101/2025.11.18.689112